1st Quarter - Report

NATIONAL COMMUNITY PHARMACISTS ASSOCIATION for NATIONAL COMMUNITY PHARMACISTS ASSOCIATION

Firm
Client
Income
—
Expenses
$340,000
Expense method
C: businesses, Internal Revenue Code section 162(e)

What was lobbied

10 issue areas, each in the filer's own words, with who lobbied on it and where.

Alcohol and Drug Abuse ALC

Controlled Substances Prescribing & Dispensing; Comments to DOJ & DEA on "Ensuring Lawful Governance and Implementing the Presidents 'Department of Government Efficiency' Deregulatory Initiative"; Comments to DEA on "Special Registrations for Telemedicine and Limited State Telemedicine Registrations [Docket No. DEA-407]"

LobbyistCovered position, as disclosed
ANNE CASSITY —
RONNA HAUSER —
KAITLIN KRELL —
STEVEN W POSTAL —
DAVID JEREMY WEISSMAN —

Contacted: SENATE; HOUSE OF REPRESENTATIVES; Justice, Dept of (DOJ); Drug Enforcement Administration (DEA)

Medicare/Medicaid MMM

S.891, the Bipartisan Health Care Act; S.882, the Patients Before Middlemen Act; S. 927, the Protecting Pharmacies in Medicaid Act; the Equitable Community Access to Pharmacist Services Act; H.R.2428, the Ensuring Access to Lower-Cost Medicines for Seniors Act; Comments to CMS on the implementation of Medicare Part D Medicare Drug Price Negotiation implementation under the Inflation Reduction Act (IRA; P.L. 117-169); Long-Term Care Pharmacy at Home Services in Medicare; Comments to CMS for its "Dispensing Entity-CMS Agreement and Dispensing Entity-MTF Data Module Contractor Agreement" (IRA; P.L.117-169)'

LobbyistCovered position, as disclosed
ANNE CASSITY —
RONNA HAUSER —
KAITLIN KRELL —
STEVEN W POSTAL —
DAVID JEREMY WEISSMAN —

Contacted: SENATE; Centers For Medicare and Medicaid Services (CMS); Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES; White House Office

Bills named: S. 882 (119th), S. 927 (119th), H.R. 2428 (119th), S. 891 (119th)

Pharmacy PHA

H.R. 2214, the Delinking Revenue from Unfair Gouging Act; H.R. 1968, the Full-Year Continuing Appropriations and Extensions Act, 2025; H.Con.Res 14/S. Con. Res. 7, Establishing the congressional budget for the United States Government for fiscal year 2025 and setting forth the appropriate budgetary levels for fiscal years 2026 through 2034;

LobbyistCovered position, as disclosed
ANNE CASSITY —
RONNA HAUSER —
KAITLIN KRELL —
STEVEN W POSTAL —
DAVID JEREMY WEISSMAN —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.Con.Res. 14 (119th), H.R. 1968 (119th), H.R. 2214 (119th), S.Con.Res. 7 (119th)

Taxation/Internal Revenue Code TAX

S.587/1301, The Death Tax Repeal Act;

LobbyistCovered position, as disclosed
ANNE CASSITY —
RONNA HAUSER —
KAITLIN KRELL —
DAVID JEREMY WEISSMAN —

Contacted: HOUSE OF REPRESENTATIVES; SENATE; Treasury, Dept of; Internal Revenue Service (IRS)

Bills named: S. 587 (119th)

Labor Issues/Antitrust/Workplace LBR

S.526, the Pharmacy Benefit Manager Transparency Act of 2025; S.527, the Prescription Pricing for the People Act of 2025;

LobbyistCovered position, as disclosed
ANNE CASSITY —
RONNA HAUSER —
KAITLIN KRELL —
DAVID JEREMY WEISSMAN —

Contacted: Federal Trade Commission (FTC); HOUSE OF REPRESENTATIVES; SENATE

Bills named: S. 527 (119th), S. 526 (119th)

Defense DEF

TRICARE Pharmacy Network Oversight & Changes;

LobbyistCovered position, as disclosed
ANNE CASSITY —
RONNA HAUSER —
KAITLIN KRELL —
DAVID JEREMY WEISSMAN —

Contacted: HOUSE OF REPRESENTATIVES; Defense, Dept of (DOD); SENATE

Budget/Appropriations BUD

H.R. 1968, the Full-Year Continuing Appropriations and Extensions Act, 2025; H.Con.Res 14/S. Con. Res. 7, Establishing the congressional budget for the United States Government for fiscal year 2025 and setting forth the appropriate budgetary levels for fiscal years 2026 through 2034;

LobbyistCovered position, as disclosed
ANNE CASSITY —
RONNA HAUSER —
KAITLIN KRELL —
DAVID JEREMY WEISSMAN —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.Con.Res. 14 (119th), H.R. 1968 (119th), S.Con.Res. 7 (119th)

Telecommunications TEC

Comments to HHS on "HIPAA Security Rule To Strengthen the Cybersecurity of Electronic Protected Health Information [HHS-OCR-0945-AA22]";

LobbyistCovered position, as disclosed
ANNE CASSITY —
RONNA HAUSER —
KAITLIN KRELL —
STEVEN W POSTAL —
DAVID JEREMY WEISSMAN —

Contacted: Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES; SENATE

Trade (domestic/foreign) TRD

Comments to CBP on "June 14, 2024, Internal Advice Letter H283420";

LobbyistCovered position, as disclosed
ANNE CASSITY —
RONNA HAUSER —
STEVEN W POSTAL —

Contacted: U.S. Customs & Border Protection; White House Office

Small Business SMB

Comments to the White House on the Corporate Transparency Act implementations (NDAA; P.L.116-283);

LobbyistCovered position, as disclosed
ANNE CASSITY —
RONNA HAUSER —
STEVEN W POSTAL —

Contacted: White House Office

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.